Tudor Investment Corp
BHVN

Tudor Investment Corp’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Tudor Investment Corp’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-475,004
Closed -$71.8M – 3053
2022
Q3 		$71.8M Buy
475,004
+147,269
+45% +$21.8M 1.55% 3
2022
Q2 		$47.8M Buy
+327,735
New +$41.9M 1.25% 3
2021
Q4 		– Sell
-3,911
Closed -$543K – 3264
2021
Q3 		$543K Buy
+3,911
New +$488K 0.01% 1601
2021
Q2 		– Sell
-92,658
Closed -$6.33M – 2181
2021
Q1 		$6.33M Buy
92,658
+88,521
+2,140% +$7.16M 0.13% 136
2020
Q4 		$355K Sell
4,137
-276
-6% -$23.4K 0.01% 1065
2020
Q3 		$287K Buy
+4,413
New +$289K 0.01% 1002
2020
Q2 		– Sell
-19,004
Closed -$647K – 1540
2020
Q1 		$647K Sell
19,004
-16,810
-47% -$769K 0.06% 387
2019
Q4 		$1.95M Buy
35,814
+21,216
+145% +$1.05M 0.09% 290
2019
Q3 		$609K Sell
14,598
-13,496
-48% -$570K 0.02% 653
2019
Q2 		$1.23M Buy
+28,094
New +$1.58M 0.04% 465

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Tudor Investment Corp's BHVN Position: Q4 2022 in Review

Tudor Investment Corp sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 475,004 shares — an estimated $71.8M sold.

Tudor Investment Corp first reported a position in BHVN in Q2 2019 and held it in 10 quarters. The position peaked at $71.8M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Tudor Investment Corp reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 475,004 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $71.8M.
  • Tudor Investment Corp first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 10 quarters.
  • Tudor Investment Corp's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $71.8M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.